Real-world evidence is increasingly critical to understanding patient outcomes from pulmonary care and pharmaceutical treatments
Century Health, a pioneer in applying AI to real-world data to accelerate research, and Nimbus Health, a technology-driven pulmonary care provider transforming how lung conditions are managed, announced a partnership to develop high-quality, real-world datasets for serious respiratory diseases. The initial focus will be on chronic obstructive pulmonary disease and asthma, with the potential to expand into other areas where innovation in treatment can significantly impact patient outcomes.
Health Technology Insights: TAG1, PharmaLogic Partner to Develop Decentralized Lead-212 Tech
Through this collaboration, Century Health’s AI-driven platform will integrate with Nimbus Health’s EHR system to curate and enrich clinical registries. These datasets will enable insights into the complex relationships between patient profiles, disease progression, and treatment outcomes. Historically, much of this data has been buried in unstructured clinical notes and reports, making it difficult to extract and analyze, even for dedicated research teams.
Health Technology Insights: Latticework Partners with First Medical Associates in Maryland
For pharmaceutical companies, analyses conducted on the datasets can help address complex real-world evidence research needs, including treatment patterns, adherence, exacerbation rates, and comparative effectiveness studies. Real-world studies are critical to understanding the effectiveness of interventions in clinical practice as a complement to highly controlled evidence from clinical trials.
COPD and asthma are two of the most prevalent and burdensome respiratory diseases. More than 17 million people in the US are living with COPD and it is projected to become the third leading cause of death worldwide by 2030. Asthma impacts over 25 million people in the US, and despite numerous available therapies, challenges in managing the condition persist. Neither condition has a definitive cure, and current treatments focus on symptom control and prevention. High-quality real-world data can play a pivotal role in informing and accelerating new therapeutic advances.
“At Nimbus Health, we’ve reimagined pulmonary care to be proactive and data-driven. We serve tens of thousands of pulmonary patients per year with a range of therapies and technological modalities. We’re excited to make our unique dataset available to pharmaceutical researchers,” said Clay Spence, CEO of Nimbus Health. “Through this collaboration, we’re proud to help drive innovation and advance outcomes for patients with respiratory diseases.”
The partnership will leverage Century Health’s AI-powered data platform to transform de-identified clinical data from Nimbus Health’s network into rich, continuously-refreshed, research-ready registries. Century Health will unlock structured insights at scale to drive better understanding of COPD and asthma in real-world settings and accelerate the development of new therapies.
“Generating real-world evidence in respiratory diseases has been limited by fragmented, hard-to-access data,” said Vish Srivastava, Co-Founder & CEO of Century Health. “The combination of Century Health’s AI capabilities and Nimbus Health’s deep clinical expertise in pulmonary care creates an unprecedented opportunity to understand disease progression and treatment in real-world settings.”
Century Health specializes in extracting validated research-grade information from unstructured clinical data, helping to surface rich real-world insights without the need for manual data abstraction. Its platform is HIPAA-compliant and SOC 2 Type 2-certified, with rigorous de-identification processes that uphold the highest standards of patient privacy and data security. Century Health maintains continuously updated registries across neurology, immunology, and respiratory diseases, offering unparalleled resources for RWE generation and research collaboration.
Health Technology Insights: Southern Healthcare Taps Vyne Medical to Automate Order Workflow
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
